Editor:
Vasilis Vasiliou

Volume 4
6 issues per year

ISSN:1479-7364
(online)

Indexed and abstracted in:

Chemical Abstracts
Medline
PubMed
 

Human Genome Organisation



Print this page Tell A Friend Add to Favorites

Editors and Editorial Board

Human Genomics is guided by its Editor, Professor Vasilis Vasiliou, and eminent international Editorial Board of leading academics and practitioners at the forefront of the human genomics community.
 
 
Editor
Vasilis Vasiliou, University of Colorado Health Sciences Center, Denver, USA

Vasilis Vasiliou is Professor at the Health Sciences Center and Director of the Toxicology Graduate Program at the University of Colorado. He obtained his Ph.D. in Biochemical Pharmacology from the University of Ioannina, Greece and then carried out his postdoctoral training in Molecular Toxicology and Pharmacogenetics at the University of Cincinnati, Ohio. His research interests include cellular responses to oxidative stress induced by physical agents and the metabolism of both endogenous and foreign chemicals; functional and comparative genomics, genetic polymorphisms and ætiology of complex diseases and molecular evolution.

Genome Update Editor
Daniel Nebert
, University of Cincinnati Medical School, USA

Software Review Editors
Thomas Schlitt, King's College London, UK
Tzu Lip Phang, University of Colorado Denver, USA
 
Research Highlights Editor
Robert Scheinman, University of Colorado Denver, USA

Book Review Editors
Michael Stumpf, Imperial College London, UK
Panagiotis A. Tsonis, University of Dayton, USA

Editorial Board

  • Stylianos Antonarakis, University of Geneva Medical Hospital, Switzerland
  • Elspeth Bruford, HUGO Gene Nomenclature Committee, UK
  • Lon Cardon, Wellcome Trust Centre for Human Genetics, UK
  • Ku Chee Seng, Cancer Science institute of Singapore, National University of Singapore, Singapore
  • Geoffrey Childs, Albert Einstein College of Medicine, USA
  • David N. Cooper, Institute of Medical Genetics, Cardiff University, UK
  • Richard G. H. Cotton, Genomic Disorders Research Centre, Australia
  • Anneke I. den Hollander, Associate Professor, Department of Ophthalmology, Radboud University Nijmegen Medical Centre, The Netherlands
  • John Danesh, Cambridge University, UK
  • Robert Desnick, Mount Sinai School of Medicine, USA
  • Anna Di Rienzo, University of Chicago, USA
  • Marcus Feldman, Stanford University, USA
  • Mirella Filocamo, G. Gaslini Institute, Italy
  • Takashi Gojobori, National Institute of Genetics, Japan
  • Lawrence Hunter, University of Colorado School of Medicine, USA
  • Tadashi Imanishi, Biomedicinal Information Research Center, Japan
  • Hidetoshi Inoko, Tokai University School of Medicine, Japan
  • Alec Jeffreys, Leicester University, UK
  • P.Y. Kwok, University of California at San Francisco, USA
  • Poh-San Lai, National University of Singapore, Singapore
  • Doron Lancet, Weizmann Institute of Science, Israel
  • Arno Motulsky, University of Washington, USA
  • Michael Nothnagel, Christian Albrechts University, Germany
  • Steve O’Brien, Laboratory of Genomic Diversity, NIH, USA
  • George P. Patrinos, University of Patras, Greece
  • David Pollock, University of Colorado School of Medicine, USA
  • David Ross, University of Colorado Health Sciences Center, USA
  • Ann Saunders, GlaxoSmithKline, USA
  • Simon Shorvon, University College London, UK
  • Mark D. Shriver, The Pennsylvania State University, USA
  • Ellen Solomon, Kings College London, UK
  • J. Claiborne Stephens, Head of Population Genetics and Pharmacogenomics, Pfizer, USA
  • Sumio Sugano, University of Tokyo, Japan
  • Simon Tavare, University of Southern California, USA
  • Michel Tibayrenc, Genetics and Infection of Infectious Diseases, IRD Centre, France
  • Mike Weale, King's College London, UK
  • Carsten Wiuf, University of Aarhus, Denmark
  • Nick Wood, University College London, UK
  • Sam Zakhari, National Institute on Alcohol Abuse and Alcoholism, NIH, USA